Mule.I have seen the posters blaming BOD on the other stocks.
My gripe is not with JW but I sure have a gripe with a couple of other directors over the years, about three in fact, maybe four.
Ross has certainly been a lifestyle director with no get up and go in him at all.
In my opinion he only has any interest now because he thinks the ground Inca has shows real promise.
This ground has come to us through no effort on the part of Ross.
Peru was a typical example of this where we waited and waited for months/years for permits with no seeming urgency from Inca management to get things through. Meanwhile the coffers simply whittled away only to once again replenish by another ridiculously discounted cash raise.
Personally, I feel that we need to get rid of the directors other than JW and I include the new Chairman in that.
What a disappointment.
Lockitt.
Some of them are doing very well now with the same directors in place and new holders very happy, one of those is RNU
- Forums
- ASX - By Stock
- ICG
- Ann: Potential For Phosphate Mineralisation at Frewena
Ann: Potential For Phosphate Mineralisation at Frewena, page-93
-
- There are more pages in this discussion • 147 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ICG (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.160M |
Open | High | Low | Value | Volume |
0.6¢ | 0.6¢ | 0.6¢ | $2.4K | 400K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 3106494 | 0.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.6¢ | 2149226 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 3106494 | 0.005 |
9 | 3180194 | 0.004 |
13 | 19206780 | 0.003 |
4 | 4399980 | 0.002 |
3 | 6199950 | 0.001 |
Price($) | Vol. | No. |
---|---|---|
0.006 | 2149226 | 7 |
0.007 | 1447760 | 5 |
0.008 | 1950160 | 4 |
0.009 | 1033282 | 3 |
0.011 | 350000 | 1 |
Last trade - 10.04am 12/11/2024 (20 minute delay) ? |
Featured News
ICG (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online